Work

Abstract 7473: A novel dual-target strategy against TNBC: Combining EZH2 inhibition and dopamine D1 receptor activation to restore immune balance

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-7473

Authors: Rajni Kant Shukla, Kate Ormiston, Gautam Sarathy, Shivani Dhekne, Dionisia Marie Quiroga, Sanjay Gupta, Daniel G. Stover, Pierre Giglio, Christian Rolfo, Eswar Shankar

Institutions: The Ohio State University Wexner Medical Center, The Ohio State University, Case Western Reserve University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148790674

Cites:

Cited by:

Related to: